Institutional investors hold a majority ownership of ABBV through the 71.71% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Major industry. Last, during the quarter ended December 2017, these large investors purchased a net $5.4 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIDELITY MANAGEMENT & RESEARCH C... Bought 6.4 Million shares of AbbVie Inc
JENNISON ASSOCIATES LLC Bought 5.2 Million shares of AbbVie Inc
CAPITAL RESEARCH & MANAGEMENT CO... Bought 4.0 Million shares of AbbVie Inc